ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TXMD TherapeuticsMD Inc

1.87
-0.02 (-1.06%)
Last Updated: 15:11:37
Delayed by 15 minutes

Period:

Draw Mode:

Volume 9,322
Bid Price 1.86
Ask Price 1.88
News -
Day High 1.982

Low
1.86

52 Week Range

High
4.725

Day Low 1.86
Company Name Stock Ticker Symbol Market Type
TherapeuticsMD Inc TXMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.02 -1.06% 1.87 15:11:37
Open Price Low Price High Price Close Price Prev Close
1.90 1.86 1.982 1.89
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
176 9,322 $ 1.89 $ 17,639 - 1.86 - 4.725
Last Trade Time Type Quantity Stock Price Currency
15:13:36 1 $ 1.87 USD

TherapeuticsMD Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
19.88M 10.58M - 1.3M -10.28M -0.97 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

TherapeuticsMD News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TXMD Message Board. Create One! See More Posts on TXMD Message Board See More Message Board Posts

Historical TXMD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.082.081.861.9330,110-0.21-10.10%
1 Month2.362.39351.862.1329,763-0.49-20.76%
3 Months2.282.751.862.2722,852-0.41-17.98%
6 Months2.383.071.862.3022,794-0.51-21.43%
1 Year3.564.7251.863.1325,215-1.69-47.47%
3 Years1.1711.690.15031.052,366,3990.7059.83%
5 Years4.2411.690.15031.553,621,174-2.37-55.90%

TherapeuticsMD Description

TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.

Your Recent History

Delayed Upgrade Clock